Signaling through the Adaptor Molecule MyD88 in CD4+ T Cells Is Required to Overcome Suppression by Regulatory T Cells
Innate immune recognition controls adaptive immune responses through multiple mechanisms. The MyD88 signaling adaptor operates in many cell types downstream of Toll-like receptors (TLRs) and interleukin-1 (IL-1) receptor family members. Cell-type-specific functions of MyD88 signaling remain poorly c...
Saved in:
Published in | Immunity (Cambridge, Mass.) Vol. 40; no. 1; pp. 78 - 90 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
16.01.2014
Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Innate immune recognition controls adaptive immune responses through multiple mechanisms. The MyD88 signaling adaptor operates in many cell types downstream of Toll-like receptors (TLRs) and interleukin-1 (IL-1) receptor family members. Cell-type-specific functions of MyD88 signaling remain poorly characterized. Here, we have shown that the T cell-specific ablation of MyD88 in mice impairs not only T helper 17 (Th17) cell responses, but also Th1 cell responses. MyD88 relayed signals of TLR-induced IL-1, which became dispensable for Th1 cell responses in the absence of T regulatory (Treg) cells. Treg cell-specific ablation of MyD88 had no effect, suggesting that IL-1 acts on naive CD4+ T cells instead of Treg cells themselves. Together, these findings demonstrate that IL-1 renders naive CD4+ T cells refractory to Treg cell-mediated suppression in order to allow their differentiation into Th1 cells. In addition, IL-1 was also important for the generation of functional CD4+ memory T cells.
•Ablation of MyD88 in T cells impairs both Th1 and Th17 cell responses•Defect is due to abrogated IL-1 signaling•Th1 cell response is recovered in the absence of Treg cells•IL-1 acts on naive or effector CD4+ T cells and not on Treg cells |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
ISSN: | 1074-7613 1097-4180 |
DOI: | 10.1016/j.immuni.2013.10.023 |